Filing Details
- Accession Number:
- 0001385508-21-000134
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-16 16:12:01
- Reporting Period:
- 2021-09-16
- Accepted Time:
- 2021-09-16 16:12:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385508 | Opiant Pharmaceuticals Inc. | OPNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1656633 | Roger Crystal | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd, Suite 280 Santa Monica CA 90401 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Par Value $0.001 | Acquisiton | 2021-09-16 | 100 | $23.44 | 5,100 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
